Estomaquil Polvo

Manufacturer
ProMex LLC
Effective date
2023-11-29
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 00:03:11

Label at a glance#

ProductEstomaquil Polvo
Active ingredientBISMUTH SUBSALICYLATE
Label structure10 sections

Indications and uses

relieves: travelers' diarrhea diarrhea upset stomach due to overindulgence in food and drink, including: heartburn indigestion nausea gas belching fullness

Dosage and administration

Adults & Children 12 yrs and older: Dissolve 2 pouches (1 dose) in 1/2 glass of water. Repeat every 1/2 to 1 hour as needed, to a maximum of 8 doses in a 24-hour period use until diarrhea stops, but not more than 2 days. If symptoms persist, consult a doctor drink plenty of clear fluids to help prevent dehydration which may accompany diarrhea Children under 12 yrs: ask a doctor

Storage and handling

each pouch contains: calcium 210 mg, magnesium 190 mg, sodium 206 mg avoid excessive heat

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each pouch)

OTC - ACTIVE INGREDIENT SECTION

Bismuth Subsalicylate 262 mg

Purpose

OTC - PURPOSE SECTION

Upset stomach reliever / Antidiarrheal

Uses

INDICATIONS & USAGE SECTION

relieves:

  • travelers' diarrhea
  • diarrhea
  • upset stomach due to overindulgence in food and drink, including:
    • heartburn
    • indigestion
    • nausea
    • gas
    • belching
    • fullness

Warnings

WARNINGS SECTION

Reye`s syndrome

SPL UNCLASSIFIED SECTION

Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea or vomiting occur, consult a doctor because these symptoms could be an early sign of Reye`s syndrome, a rare but serious illness

Allergy alert

SPL UNCLASSIFIED SECTION

Contains salicylate. Do not take if you are:

  • allergic to salicylate (including aspirin)
  • taking other salicylate products

Do not use if you have

OTC - DO NOT USE SECTION

  • an ulcer
  • a bleeding problem

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • fever
  • mucus in the stool

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking any drug for:

  • anticoagulation (thinning the blood)
  • diabetes
  • gout
  • arthritis

OTC - WHEN USING SECTION

When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • symptoms get worse
  • ringing in the ears or loss of hearing occurs
  • diarrhea lasts more than 2 days

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children. In case of overdose, seek professional help or contact a poison control center immediately

Directions

DOSAGE & ADMINISTRATION SECTION

  • Adults & Children 12 yrs and older: Dissolve 2 pouches (1 dose) in 1/2 glass of water. Repeat every 1/2 to 1 hour as needed, to a maximum of 8 doses in a 24-hour period
    • use until diarrhea stops, but not more than 2 days. If symptoms persist, consult a doctor
    • drink plenty of clear fluids to help prevent dehydration which may accompany diarrhea
  • Children under 12 yrs: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • each pouch contains: calcium 210 mg, magnesium 190 mg, sodium 206 mg
  • avoid excessive heat

Inactive ingredients

INACTIVE INGREDIENT SECTION

anhydrous citric acid, calcium carbonate, magnesium hydroxide, maltodextrin, silicon dioxide, sodium bicarbonate, tartaric acid

SPL UNCLASSIFIED SECTION

Distributed By:
PRO-MEX®
P.O. Box 63-0716
Miami, FL. 33163

PRINCIPAL DISPLAY PANEL - 3.0 g Pouch Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ESTOMAQUIL®

Bismuth Subsalicylate 262 mg

Relief for:

  • Nausea
  • Heartburn
  • Diarrhea
  • Fullness

Maximum Strength

10 Pouches
0.1 oz (3.0 g) Each

Principal Display Panel - 3.0 g Pouch Carton
Principal Display Panel - 3.0 g Pouch Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1721449bismuth subsalicylate 262 MG Powder for Oral SuspensionPSN4
1721455Estomaquil 262 MG Powder for Oral SuspensionPSN4
1721455bismuth subsalicylate 262 MG Powder for Oral Suspension [Estomaquil]SBD4
1721449bismuth subsalicylate 262 MG Powder for Oral SuspensionSCD4
1721455Estomaquil 262 MG Powder for Oral SuspensionSY4

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58988-1080-1Estomaquil Polvo10 in 1 CARTONPOWDER104
58988-1080-1Estomaquil Polvo1 in 1 POUCHPOWDER14
58988-1080-2Estomaquil Polvo20 in 1 CARTONPOWDER204
58988-1080-2Estomaquil Polvo1 in 1 POUCHPOWDER14
58988-1080-3Estomaquil Polvo50 in 1 CARTONPOWDER504
58988-1080-3Estomaquil Polvo1 in 1 POUCHPOWDER14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58988-1080ESTOMAQUIL POLVO (BISMUTH SUBSALICYLATE) POWDER [PROMEX LLC]4Current NDC, Legacy NDC, 6 package rows20231202_cf94c99a-c489-45ec-bb13-3e6959e377de.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BISMUTH SUBSALICYLATEACTIVE INGREDIENT62TEY51RR11
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZ1
CALCIUM CARBONATEINACTIVE INGREDIENTH0G9379FGK1
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QP1
MAGNESIUM HYDROXIDEINACTIVE INGREDIENTNBZ3QY004S1
SODIUM BICARBONATEINACTIVE INGREDIENT8MDF5V39QO1
TARTARIC ACIDINACTIVE INGREDIENTW4888I119H1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
58988-108058988-1080-1, 58988-1080-2, 58988-1080-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 184 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOGUM, CHEWING / ORAL360 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, EXTENDED RELEASE / ORAL81 mgExact identifier — unii+route
68 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HTABLET, FILM COATED / ORAL30 mgExact identifier — unii+route
48 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOPOWDER, FOR SOLUTION / ORAL1250 mg/100mlExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, ORALLY DISINTEGRATING / ORAL107 mgExact identifier — unii+route
68 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKCAPSULE, EXTENDED RELEASE / ORAL4 mgExact identifier — unii+route
40 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET / ORAL793 mgExact identifier — unii+route
40 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, DELAYED RELEASE / ORAL30 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOCAPSULE / ORAL320 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOSOLUTION / ORALADJ PHExact identifier — unii+route
68 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, EXTENDED RELEASE / ORAL229.7 mgExact identifier — unii+route
40 equally ranked IID candidates
MAGNESIUM HYDROXIDEMAGNESIUM HYDROXIDENBZ3QY004STABLET, CHEWABLE / ORAL750 mgExact identifier — unii+route
24 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOCAPSULE, DELAYED RELEASE PELLETS / ORAL4 mgExact identifier — unii+route
68 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, DELAYED RELEASE / ORAL8.4 mgExact identifier — unii+route
40 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HTABLET, EXTENDED RELEASE / ORAL96 mgExact identifier — unii+route
48 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HTABLET, FILM COATED / ORAL30 mgExact identifier — unii+route
48 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, CHEWABLE / ORAL1650 mgExact identifier — unii+route
40 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOFILM, SOLUBLE / ORAL2 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOCAPSULE, DELAYED RELEASE PELLETS / ORAL4 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET / ORAL1300 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOSOLUTION / ORALADJ PHExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, CHEWABLE / ORAL140 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOFILM, SOLUBLE / ORAL2 mgExact identifier — unii+route
68 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HPELLET / ORAL354 mgExact identifier — unii+route
48 equally ranked IID candidates
MAGNESIUM HYDROXIDEMAGNESIUM HYDROXIDENBZ3QY004SCAPSULE, DELAYED RELEASE / ORAL6.7 mgExact identifier — unii+route
24 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, FILM COATED / ORAL86 mgExact identifier — unii+route
68 equally ranked IID candidates
MAGNESIUM HYDROXIDEMAGNESIUM HYDROXIDENBZ3QY004STABLET, DELAYED RELEASE / ORAL150 mgExact identifier — unii+route
24 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, FILM COATED / ORAL300 mgExact identifier — unii+route
40 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOGRANULE, EFFERVESCENT / ORAL267 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, DELAYED RELEASE / ORAL30 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOGUM, CHEWING / ORAL360 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, CHEWABLE / ORAL140 mgExact identifier — unii+route
68 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HTABLET, COATED / ORAL10 mgExact identifier — unii+route
48 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOFILM, SOLUBLE / ORAL2 mgExact identifier — unii+route
68 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HPELLET / ORAL354 mgExact identifier — unii+route
48 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, EFFERVESCENT / ORAL57600 mgExact identifier — unii+route
68 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKCAPSULE / ORAL349.9 mgExact identifier — unii+route
40 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HCAPSULE, EXTENDED RELEASE / ORAL1325 mgExact identifier — unii+route
48 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HTABLET, EXTENDED RELEASE / ORAL96 mgExact identifier — unii+route
48 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOPOWDER, FOR SOLUTION / ORAL1250 mg/100mlExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, ORALLY DISINTEGRATING / ORAL107 mgExact identifier — unii+route
68 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET / ORAL793 mgExact identifier — unii+route
40 equally ranked IID candidates
MAGNESIUM HYDROXIDEMAGNESIUM HYDROXIDENBZ3QY004SCAPSULE, DELAYED RELEASE / ORAL6.7 mgExact identifier — unii+route
24 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, DELAYED RELEASE / ORAL30 mgExact identifier — unii+route
68 equally ranked IID candidates
MAGNESIUM HYDROXIDEMAGNESIUM HYDROXIDENBZ3QY004STABLET, CHEWABLE / ORAL750 mgExact identifier — unii+route
24 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPPOWDER / ORAL840 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HCAPSULE, EXTENDED RELEASE / ORAL1325 mgExact identifier — unii+route
48 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, FILM COATED / ORAL86 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOTABLET, CHEWABLE / ORAL140 mgExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOPOWDER, FOR SOLUTION / ORAL1250 mg/100mlExact identifier — unii+route
68 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOLOZENGE / ORAL100 mgExact identifier — unii+route
68 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HTABLET, ORALLY DISINTEGRATING / ORAL45 mgExact identifier — unii+route
48 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HCAPSULE / ORAL400 mgExact identifier — unii+route
48 equally ranked IID candidates
SODIUM BICARBONATESODIUM BICARBONATE8MDF5V39QOPOWDER, FOR SOLUTION / ORAL1250 mg/100mlExact identifier — unii+route
68 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HTABLET, ORALLY DISINTEGRATING / ORAL45 mgExact identifier — unii+route
48 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKCAPSULE, EXTENDED RELEASE / ORAL4 mgExact identifier — unii+route
40 equally ranked IID candidates
MAGNESIUM HYDROXIDEMAGNESIUM HYDROXIDENBZ3QY004SPOWDER, FOR SUSPENSION / ORAL0.01 mgExact identifier — unii+route
24 equally ranked IID candidates
MAGNESIUM HYDROXIDEMAGNESIUM HYDROXIDENBZ3QY004STABLET, CHEWABLE / ORAL750 mgExact identifier — unii+route
24 equally ranked IID candidates
TARTARIC ACIDTARTARIC ACIDW4888I119HSUSPENSION / ORAL40 mgExact identifier — unii+route
48 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKCAPSULE / ORAL349.9 mgExact identifier — unii+route
40 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Estomaquil PolvoBISMUTH SUBSALICYLATEProMex LLCcf94c99a-c489-45ec-bb13-3e6959e377de2023-11-29WarningsExact identifier
ndc (package): 58988-1080-3
ndc (package): 58988-1080-2
ndc (package): 58988-1080-1
ndc (product): 58988-1080
ndc11 (package): 58988108002
ndc11 (package): 58988108001
ndc11 (package): 58988108003
spl id: b60909fc-e262-4ad4-bb96-e09b71b38e1c
spl set id: cf94c99a-c489-45ec-bb13-3e6959e377de

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.